Stockreport

Humacyte, Inc. Announces Proposed Public Offering of Common Stock

Humacyte, Inc.  (HUMA) 
PDF DURHAM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioe [Read more]